Last €22.42 EUR
Change Today +0.065 / 0.29%
Volume 0.0
OFX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:04 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

orthofix international nv (OFX) Snapshot

Open
€22.42
Previous Close
€22.35
Day High
€22.42
Day Low
€22.42
52 Week High
04/18/13 - €25.33
52 Week Low
12/12/13 - €14.49
Market Cap
407.7M
Average Volume 10 Days
23.5
EPS TTM
--
Shares Outstanding
18.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORTHOFIX INTERNATIONAL NV (OFX)

orthofix international nv (OFX) Related Businessweek News

No Related Businessweek News Found

orthofix international nv (OFX) Details

Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical devices used principally by musculoskeletal medical specialists for spine and orthopedic applications. The company operates in four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment offers a range of devices for use as adjunctive treatment to enhance fusion success in cervical and lumbar spine fusion, as well as a therapeutic treatment for non-healing fractures outside of the spine. The Biologics segment provides a portfolio of regenerative products that allow physicians to treat a range of spinal and orthopedic conditions under the Trinity Evolution and Trinity Elite names. The Extremity Fixation segment offers orthopedic products used in fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment provides a range of implant products used in surgical procedures of the spine. The company markets and distributes its products directly to hospitals, doctors, and other healthcare providers in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Brazil, Australia, and Puerto Rico, as well as through independent distributors, sales representatives, and affiliates in other markets. Orthofix International N.V. was founded in 1987 and is headquartered in Curaçao, the Netherlands Antilles.

889 Employees
Last Reported Date: 03/31/14
Founded in 1987

orthofix international nv (OFX) Top Compensated Officers

Chief Financial Officer and Principal Account...
Total Annual Compensation: $272.7K
Chief Strategy Officer
Total Annual Compensation: $417.7K
Chief Administrative Officer, General Counsel...
Total Annual Compensation: $397.1K
Compensation as of Fiscal Year 2012.

orthofix international nv (OFX) Key Developments

Orthofix International N.V., Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013

Orthofix International N.V., reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported net sales of $106,143,000 against $117,365,000 a year ago. Operating loss was $6,378,000 against operating income of $25,613,000 a year ago. Loss before income taxes was $8,303,000 against income before income taxes of $24,108,000 a year ago. Net loss from continuing operations, net of tax was $9,337,000 or $0.52 per diluted share against net income from continuing operations, net of tax of $16,009,000 or $0.81 per diluted share a year ago. Net loss was $10,836,000 or $0.60 per diluted share against $21,161,000 or $1.07 per diluted share a year ago. Adjusted operating income was $3,902,000 against $25,848,000 a year ago. Adjusted net loss was $2,209,000 or $0.12 per diluted share against adjusted net income of $17,324,000 or $0.88 per diluted share a year ago. For the full year, the company reported net sales of $400,534,000 against $447,581,000 a year ago. Operating loss was $5,087,000 against operating income of $76,636,000 a year ago. Loss before income taxes was $6,522,000 against income before income taxes of $70,188,000 a year ago. Net loss from continuing operations, net of tax was $15,681,000 or $0.84 per diluted share against net income from continuing operations, net of tax of $45,050,000 or $2.32 per diluted share a year ago. Net loss was $28,475,000 or $1.52 per diluted share against $42,838,000 or $2.21 per diluted share a year ago. Net cash provided by operating activities was $67,445,000 against $10,186,000 a year ago. Capital expenditures were $30,242,000 against $28,774,000 a year ago. Adjusted operating income was $34,160,000 against $84,031,000 a year ago. Adjusted net income was $14,232,000 or $0.76 per diluted share against $49,711,000 or $2.56 per diluted share a year ago.

Orthofix International N.V. Announces Restatement of Earnings Results for the Years Ended December 31, 2012, December 31, 2011 and December 31, 2010

Orthofix International N.V. announced restatement of earnings results for the years ended December 31, 2012, December 31, 2011 and December 31, 2010. For the year ended December 31, 2012, the company announced reduction in net sales of $14.7 million. Decrease in net income from continuing operations of $8.9 million. The restated financial statements were prepared by the company's management in conjunction with the previously announced independent review into these matters conducted by the Audit Committee. The scope of the Independent Review, which was determined by the Audit Committee in consultation with outside professionals engaged by the Audit Committee, focused primarily on revenue recognition related to distributor arrangements and inventory reserve adjustments. In conjunction with the Independent Review, management concluded that errors existed in the company's previously issued consolidated financial statements with respect to fiscal years 2012, 2011 and 2010, and the first quarter of 2013. For the year ended December 31, 2011, the company announced reduction in net sales of $28.2 million. Decrease in net income from continuing operations of $14.5 million. For the year ended December 31, 2010, the company announced increase in net sales of $1.9 million. Increase in net income from continuing operations of $3.2 million.

Orthofix International N.V. to Report Q4, 2013 Results on Mar 27, 2014

Orthofix International N.V. announced that they will report Q4, 2013 results at 6:00 AM, US Eastern Standard Time on Mar 27, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OFX:GR €22.42 EUR +0.065

OFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.42 USD +0.02
ArthroCare Corp $48.61 USD +0.11
Globus Medical Inc $22.88 USD -0.16
LDR Holding Corp $25.12 USD +0.61
Wright Medical Group Inc $28.42 USD +0.03
View Industry Companies
 

Industry Analysis

OFX

Industry Average

Valuation OFX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTHOFIX INTERNATIONAL NV, please visit www.orthofix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.